BRIEF published on 04/14/2026 at 18:05, 10 days 12 hours ago Launch of genOway franchises in Canada and Australia Revenue International Development GenOway Franchises Canada And Australia ROUTE50+DATA Strategy
BRIEF published on 03/30/2026 at 18:50, 25 days 11 hours ago GenOway: Solid 2025 annual results despite a slight decrease in revenue EBITDA GenOway Route50+ Growth 2026 2025 Results
BRIEF published on 03/25/2026 at 18:05, 30 days 12 hours ago GenOway establishes a presence in Japan with a new subsidiary Life Sciences International Expansion Japan Market Preclinical Research GenOway Japan
BRIEF published on 01/26/2026 at 18:05, 2 months 29 days ago Genoway anticipates dynamic growth in 2026 International Expansion GenOway Growth 2026 ROUTE50+DATA Preclinical Solutions
BRIEF published on 01/19/2026 at 18:35, 3 months 5 days ago Half-year review of the liquidity contract for genOway as of December 31, 2025 Liquidity Contract Biotechnology PORTZAMPARC Euronext Growth GenOway
BRIEF published on 01/19/2026 at 15:05, 3 months 5 days ago GenOway Announces the Publication of its 2025 Annual Revenue Biotechnology Investment Webinar Financial Publication GenOway
BRIEF published on 12/16/2025 at 07:35, 4 months 8 days ago GenOway expands its strategic plan with ROUTE50+DATA Acquisition Preclinical Data Science GenOway ROUTE50+DATA
BRIEF published on 11/18/2025 at 18:35, 5 months 6 days ago GenOway: Accelerated Growth in China by genOway Shanghai Profitability China Growth Immuno-oncology GenOway
BRIEF published on 09/22/2025 at 18:05, 7 months 2 days ago Solid half-year results for genOway despite declining revenue EBITDA Half-year Results Investments GenOway Route50+
BRIEF published on 07/22/2025 at 18:05, 9 months 2 days ago GenOway's first half 2025 results: revenue down 10% Investment Growth Turnover GenOway ROUTE 50+
Published on 04/25/2026 at 03:10, 3 hours ago BEACN Announces Financial Results for Year Ended December 31, 2025
Published on 04/24/2026 at 22:05, 8 hours 5 minutes ago Critical Elements Mourns the Loss of Director Marc Simpson
Published on 04/24/2026 at 22:00, 8 hours 10 minutes ago Kidoz Inc. to Present 2025 Results and Highlight Platform Expansion and Business Momentum
Published on 04/24/2026 at 15:00, 15 hours 10 minutes ago Norsemont Reports Significant Copper, Lead & Zinc Values in Three Choquelimpie Drill Holes
Published on 04/24/2026 at 15:00, 15 hours 10 minutes ago First Canadian Graphite Appoints Scott Kelly As Chief Financial Officer
Published on 04/24/2026 at 22:43, 7 hours 27 minutes ago EQS-Adhoc: Marley Spoon Group SE: Closing of the financing transaction in connection with the financial restructuring of its German subsidiary Marley Spoon SE with increased financing amou
Published on 04/24/2026 at 22:05, 8 hours 5 minutes ago Berlin Heals Presents Positive Late Breaking Results from the CMIC-III First-In-Human Less Invasive Study
Published on 04/24/2026 at 18:12, 11 hours 58 minutes ago EQS-Adhoc: clearvise AG reviews dividend proposal in line with its dividend strategy and postpones Annual General Meeting
Published on 04/24/2026 at 18:07, 12 hours 3 minutes ago DEAG sets new records for revenue and earnings in financial year 2025 – excellently positioned for long-term growth
Published on 04/24/2026 at 18:05, 12 hours 4 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 04/24/2026 at 17:45, 12 hours 25 minutes ago Imerys-04-2026-information-share-capital-and-voting-rights-as-of-31-March-2026
Published on 04/24/2026 at 16:37, 13 hours 33 minutes ago Availability of the 2025 Universal Registration Document (URD)
Published on 04/23/2026 at 19:27, 1 day 10 hours ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 1 day 11 hours ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
